Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Sartiani

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Canadian Journal of Physiology and Pharmacology|February 24, 2009
Electrophysiologic changes in heart failure: focus on pacemaker channelsLaura Sartiani, Francesca Stillitano, Elisabetta Cerbai, et al.
Current Drug Targets|June 2, 2015
Updates on HCN Channels in the Heart: Function, Dysfunction and PharmacologyLaura Sartiani, Maria Novella Romanelli, Alessandro Mugelli, et al.
Frontiers in Cardiovascular Medicine|October 7, 2022
Pharmacological basis of the antifibrotic effects of pirfenidone: Mechanistic insights from cardiac <i>in-vitro</i> and <i>in-vivo</i> modelsLaura Sartiani, Gianluca Bartolucci, Marco Pallecchi, et al.
The Journal of Physiology|November 16, 2002
Functional expression of the hyperpolarization-activated, non-selective cation current I(f) in immortalized HL-1 cardiomyocytesLaura Sartiani, Pascal Bochet, Elisabetta Cerbai, et al.
Pharmacological Research|February 8, 2008
Expression of the hyperpolarization-activated current, I(f), in cultured adult rat ventricular cardiomyocytes and its modulation by hypertrophic factorsFrancesca Stillitano, Laura Sartiani, Petra DePaoli, et al.
Journal of Cardiovascular Pharmacology|April 30, 2003
Treatment with irbesartan counteracts the functional remodeling of ventricular myocytes from hypertensive ratsElisabetta Cerbai, Petra De Paoli, Laura Sartiani, et al.
Pharmacological Reviews|September 8, 2017
The Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion ChannelsLaura Sartiani, Guido Mannaioni, Alessio Masi, et al.
Canadian Journal of Physiology and Pharmacology|July 4, 2018
Hyperpolarization-activated cyclic-nucleotide-gated channels: pathophysiological, developmental, and pharmacological insights into their function in cellular excitabilityValentina Spinelli, Laura Sartiani, Alessandro Mugelli, et al.
Frontiers in Pharmacology|January 21, 2020
Pharmacological Inhibition of Serine Proteases to Reduce Cardiac Inflammation and Fibrosis in Atrial FibrillationRaffaele Coppini, Lorenzo Santini, Chiara Palandri, et al.
Biochemical and Biophysical Research Communications|April 10, 2007
Quantitative mRNA analysis of serotonin 5-HT4 receptor isoforms, calcium handling proteins and ion channels in human atrial fibrillationFrank Lezoualc'h, Klaudia Steplewski, Laura Sartiani, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Canadian Journal of Physiology and Pharmacology|February 24, 2009
Electrophysiologic changes in heart failure: focus on pacemaker channelsLaura Sartiani, Francesca Stillitano, Elisabetta Cerbai, et al.
Current Drug Targets|June 2, 2015
Updates on HCN Channels in the Heart: Function, Dysfunction and PharmacologyLaura Sartiani, Maria Novella Romanelli, Alessandro Mugelli, et al.
Frontiers in Cardiovascular Medicine|October 7, 2022
Pharmacological basis of the antifibrotic effects of pirfenidone: Mechanistic insights from cardiac <i>in-vitro</i> and <i>in-vivo</i> modelsLaura Sartiani, Gianluca Bartolucci, Marco Pallecchi, et al.
The Journal of Physiology|November 16, 2002
Functional expression of the hyperpolarization-activated, non-selective cation current I(f) in immortalized HL-1 cardiomyocytesLaura Sartiani, Pascal Bochet, Elisabetta Cerbai, et al.
Pharmacological Research|February 8, 2008
Expression of the hyperpolarization-activated current, I(f), in cultured adult rat ventricular cardiomyocytes and its modulation by hypertrophic factorsFrancesca Stillitano, Laura Sartiani, Petra DePaoli, et al.
Journal of Cardiovascular Pharmacology|April 30, 2003
Treatment with irbesartan counteracts the functional remodeling of ventricular myocytes from hypertensive ratsElisabetta Cerbai, Petra De Paoli, Laura Sartiani, et al.
Pharmacological Reviews|September 8, 2017
The Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion ChannelsLaura Sartiani, Guido Mannaioni, Alessio Masi, et al.
Canadian Journal of Physiology and Pharmacology|July 4, 2018
Hyperpolarization-activated cyclic-nucleotide-gated channels: pathophysiological, developmental, and pharmacological insights into their function in cellular excitabilityValentina Spinelli, Laura Sartiani, Alessandro Mugelli, et al.
Frontiers in Pharmacology|January 21, 2020
Pharmacological Inhibition of Serine Proteases to Reduce Cardiac Inflammation and Fibrosis in Atrial FibrillationRaffaele Coppini, Lorenzo Santini, Chiara Palandri, et al.
Biochemical and Biophysical Research Communications|April 10, 2007
Quantitative mRNA analysis of serotonin 5-HT4 receptor isoforms, calcium handling proteins and ion channels in human atrial fibrillationFrank Lezoualc'h, Klaudia Steplewski, Laura Sartiani, et al.
Pageof 5